JOA - 2026-10-07 - Journal Article
Early Readmission and Mortality Across Periprosthetic Joint Infection Trajectories After Revision Arthroplasty.
Yao W, Chen S, Chen X, Yang J, Pei F, Wang D, Xu H, Zhou Z
Topics
Key Takeaway
Post-revision PJI occurred in 3.5% of revision arthroplasty patients and was associated with a 3.51-fold increase in all-cause mortality and 4.39-fold increase in 90-day readmission compared to those without post-revision PJI.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study examined whether a trajectory-based framework—categorizing patients by index revision indication (septic vs. aseptic) and subsequent post-revision PJI status—better stratifies readmission and mortality risk than infection history alone. Among 1,228 revision hip and knee arthroplasty patients, post-revision PJI developed in 43 (3.5%) and was associated with adjusted OR 4.39 for 90-day readmission and adjusted HR 3.51 for all-cause mortality. The highest-risk trajectory—index revision for PJI followed by recurrent PJI—carried an adjusted HR of 5.31 for mortality.
Key Limitation
The single-center retrospective design with only 43 post-revision PJI events limits statistical power and generalizability, and the exploratory trajectory classification has not been externally validated.
Original Abstract
BACKGROUND
Revision for periprosthetic joint infection (PJI) carries greater morbidity than aseptic revision, but infection history alone does not distinguish patients who remain infection-free from those who develop recurrent PJI. We examined readmission and mortality across an exploratory revision-infection trajectory framework.
METHODS
We retrospectively analyzed 1,228 patients who underwent revision hip or knee arthroplasty between September 30, 2008, and September 1, 2024. Patients were categorized into four trajectory groups according to the indication for index revision and subsequent post-revision PJI status. Outcomes were 90-day unplanned readmission after index revision and all-cause mortality. Because post-revision PJI status was determined during follow-up, 90-day readmission was interpreted descriptively as an early feature of the observed trajectory; mortality was evaluated using Cox proportional hazards models.
RESULTS
Post-revision PJI occurred in 43 patients (3.5%). The median follow-up was 73.7 months (range, 0.7 to 202.2). Among patients who developed post-revision PJI during follow-up, six of 43 (14.0%) had a 90-day readmission, compared with 54 of 1,185 (4.6%) without post-revision PJI (adjusted odds ratio (OR), 4.39; 95% confidence interval (CI), 1.69 to 11.42; P = 0.002). The highest observed readmission rate was in the trajectory defined by index revision for PJI followed by recurrent PJI (five of 30 [16.7%]). In Cox proportional hazards analyses, post-revision PJI was associated with mortality (adjusted hazard ratio (HR), 3.51; 95% CI, 1.34 to 9.22; P = 0.011); this trajectory also had the highest mortality point estimate (adjusted HR, 5.31; 95% CI, 1.88 to 15.00; P = 0.002).
CONCLUSIONS
Early readmission was more common among patients whose trajectories included post-revision PJI, whereas the trajectory defined by index revision for PJI followed by recurrent PJI had the highest observed mortality. The sequence of revision and infection events may provide more context than infection history alone, but these exploratory associations require external validation.